NantKwest(NK)

合作开发通用实体瘤NK样细胞疗法，新锐B轮融资超5亿

医麦客2023-02-19 07:37

2023年2月19日/医麦客新闻 eMedClub News/--近日，临床阶段公司GAIA BioMedicine宣布和TreeFrog Therapeutics合作，利用TreeFrog 的C-Stem™技术大规模扩增针对实体瘤的同种异体NK样细胞，进而解决NK样细胞的供应难题。早在2021年，TreeFrog Therapeutics完成了7500万美元的B轮融资以推进C-Stem:...查看全文

资本主义拉美行不通2022-05-11 09:16

回复@进雪球做方丈: 制造业占比高的国家，你可以拉个清单看看都是些什么国家。Industry (including construction), value added (% of GDP) | Data (worldbank.org){Industry (including construction), value added (% of GDP) | Data (worldbank.org)}
网页链接查看全文

$NantKwest(NK)$ 8-K - Current report Filed: 2019-06-07 AccNo: 0001193125-19-168170 Size: 261 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission of ...

$NantKwest(NK)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-08 AccNo: 0001564590-19-017179 Size: 9 MB 网页链接

$NantKwest(NK)$ DEF 14A - Other definitive proxy statements Filed: 2019-04-26 AccNo: 0001193125-19-122311 Size: 1 MB 网页链接

$NantKwest(NK)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-04-01 AccNo: 0001193125-19-094504 Size: 88 KB 网页链接

$NantKwest(NK)$ 内部交易: 2019-03-21,Chairman and CEO,SOON-SHIONG PATRICK ,期权,1851500普通股, $2.20

$NantKwest(NK)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-13 AccNo: 0001564590-19-007562 Size: 16 MB 网页链接

$NantKwest, Inc.(NK)$ 内部交易: 2018-11-27,Director,GORLIN STEVE ,卖出,100000普通股, $1.75

$NantKwest, Inc.(NK)$ 内部交易: 2018-11-23,Director,GORLIN STEVE ,卖出,9312普通股, $2.01

$NantKwest, Inc.(NK)$ 内部交易: 2018-11-21,Director,GORLIN STEVE ,卖出,22900普通股, $2.02

$NantKwest, Inc.(NK)$ 内部交易: 2018-11-14,Director,GORLIN STEVE ,卖出,115930普通股, $2.21